• Listed Companies
  • Announcements
  • TIANJIN DEV
  • EN
  • 繁
  • 简
  • Dec 05, 2022
    20:54

    Announcement Pursuant to Rule 13.18 of the Listing Rules

    Loan Agreement with Specific Performance Covenant

    00882 - TIANJIN DEV


  • Nov 29, 2022
    19:17

    Notice of Extraordinary General Meeting

    Closure of Books or Change of Book Closure Period

    00882 - TIANJIN DEV


  • Nov 29, 2022
    19:14

    Form of Proxy for Extraordinary General Meeting to be held on 21 December 2022

    Proxy Forms

    00882 - TIANJIN DEV


  • Nov 29, 2022
    19:11

    Proposed Revision of Annual Caps of the 2021 Steam Purchase Master Agreement and Notice of Extraordinary General Meeting

    Documents on Display

    00882 - TIANJIN DEV


  • Nov 11, 2022
    18:06

    Proposed Revision of Annual Caps of the 2021 Steam Purchase Master Agreement

    Continuing Connected Transaction

    00882 - TIANJIN DEV


  • Oct 27, 2022
    07:00

    Unaudited Financial Results for the nine months ended 30 September 2022 of Tianjin Lisheng Pharmaceutical Co., Ltd.

    Results of a Subsidiary

    00882 - TIANJIN DEV


  • Sep 07, 2022
    16:31

    Interim Dividend for the six months ended 30 June 2022 (Revised)

    Dividend or Distribution (Announcement Form)

    00882 - TIANJIN DEV


  • Aug 30, 2022
    16:39

    Interim Dividend for the six months ended 30 June 2022

    Dividend or Distribution (Announcement Form)

    00882 - TIANJIN DEV


  • ‹
  • 1
  • 2
  • ...
  • 12
  • 13
  • 14
  • ...
  • 57
  • 58
  • ›
  • »

Address

1/F, China Building,
29 Queen's Road Central, Hong Kong
(852) 3693 2688
info@cre8corp.com

Sitemap

  • Listed Companies
  • Disclaimer
  • Privacy Policy

Newsletter

Fill your email and sign up for monthly newsletter to keep updated

© Cre8ir 2025 All right reserved.